ACT Outpatient and Inpatient Trials
August 9, 2023 | Sanjit Jolly and C. Michael Gibson discuss if colchicine and rivaroxaban plus aspirin can slow disease progression in patients hospitalized with COVID-19. |
TCTMD Talking Points
2023-08-09T17:30:00Z